Quick Answer
ACRO BIOMEDICAL CO., LTD. reported Total Revenue of $0.00 for the year ending 2025.
- This data is from ACRO BIOMEDICAL CO., LTD.'s annual report (Form 10-K), filed with the SEC on February 11, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2017: $1.45 million | Q1 2018: $1.96 million | Q1 2021: $99.5 thousand | Q1 2022: $298.5 thousand | Q2 2022: $0.00 | Q3 2022: $0.00 | Q1 2023: $0.00 | Q2 2023: $0.00 | Q3 2023: $0.00 | Q1 2024: $0.00 | Q2 2024: $0.00 | Q3 2024: $0.00 | Q1 2025: $0.00 | Q2 2025: $0.00 | Q3 2025: $0.00.
- Over the full 5 years of available data (2021 to 2025), ACRO BIOMEDICAL CO., LTD.'s Total Revenue has declined by 100.0%.
- Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2024: $0.00 | Fiscal year 2023: $0.00 | Fiscal year 2022: $658.5 thousand | Fiscal year 2021: $1.20 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: